Medivation Inc. (NASDAQ: MDVN) said on Wednesday that the Alzheimer drug Dimebon, that it has been working on in collaboration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE